Regen Lab UK at BAMAN Autumn Aesthetic Conference 2026

Regen Lab UK will be attending the BAMAN Autumn Aesthetic Conference 2026 on 24-25 September at The Eastside Rooms, Birmingham, joining healthcare professionals to discuss the evolving landscape of platelet-rich plasma (PRP) and autologous biologics in the United Kingdom.

As regenerative medicine continues to gain interest across aesthetic and medical practice, the conversation is increasingly focused on quality, standardisation, patient safety, traceability, professional competence, and clinical governance.

Beyond PRP: The Importance of Standardisation

PRP is often discussed as a single treatment category, yet significant differences can exist between preparation methods and systems.

Responsible preparation of autologous biologics requires more than blood collection and centrifugation. It requires appropriate medical devices, validated preparation procedures, traceability, documentation, infection-control measures, and healthcare professionals trained to use them correctly.

For clinicians, understanding how biological preparations are produced is becoming as important as understanding how they are used in practice.

3

A Platform for Autologous Biologics

Regen Lab UK offers a range of solutions designed for the point-of-care preparation of autologous biologics, supporting a structured approach to regenerative medicine:

  • Prime: plasma, serum, and fibrin-rich preparations.
  • Regenerate: standardised RegenPRP™ preparations designed to support consistency and traceability.
  • Augment: platelet activation and the release of platelet-derived biological mediators.
  • Rebuild: Cellular Matrix, combining RegenPRP™ with non-crosslinked hyaluronic acid within a single preparation platform.

These solutions support clinicians in delivering standardised preparation processes.

The Role of Education

Technology alone does not establish clinical competence. Ongoing education remains essential for healthcare professionals seeking to integrate regenerative medicine into clinical practice.

The BioBridge Foundation, an independent educational organisation, provides CPD-focused learning opportunities for healthcare professionals through:

  • Scientific Forum Dinners, bringing together experts to review clinical evidence and discuss current practice.
  • Clinical Training Days, covering biological principles, patient pathways, aseptic preparation techniques, traceability, documentation, and practical implementation.

These educational initiatives aim to support evidence-based practice and responsible clinical adoption of regenerative medicine technologies.

3

Continuing the Discussion

Earlier this month, the BioBridge Foundation hosted an Expert Dinner Forum in London focused on regenerative sexual medicine and andrology. The event brought together clinicians and researchers to explore the current evidence, emerging applications, and governance considerations surrounding regenerative therapies.

At BAMAN Birmingham, these broader discussions continue within the medical aesthetic nursing community.

Nurses play a key role in patient education, informed consent, infection prevention, documentation, traceability, aftercare, and overall clinical governance. As regenerative medicine evolves, these topics remain central to safe and effective patient care.

Meet Regen Lab UK at BAMAN

BAMAN Autumn Aesthetic Conference 2026
24-25 September 2026
The Eastside Rooms, Birmingham
Stand 25

Join Regen Lab UK to explore how standardised preparation systems, evidence-based practice, and ongoing professional education can support the responsible development of regenerative medicine in the UK.

About Us

Since 2003, Regen Lab SA has specialized in designing and manufacturing high-quality medical devices for cell therapies and the preparation of autologous platelet-rich plasma (PRP) from the patient's own blood for bedside procedures.

Milestones

2003 - Foundation
2010 - RegenKit first approval in bone graft
2013 - A new state-of-theart laboratory in Lausanne
2014 - Cellular Matrix first approval
2015 - Launch of Cellular Matrix in Europe

Vision

Founded in 2003, Regen Lab has become a global reference thanks to its commitment to innovation, quality, and the effectiveness of its therapeutic solutions. Here’s how we have transformed the medical landscape over the past two decades.

RegenPRP™

RegenPRP™ is a medical treatment that uses platelet-rich plasma from the patient's own blood to enhance and tissue regeneration.

RegenPRP™ - HA

RegenPRP™ - HA combination is an innovative treatment combining platelet-rich plasma (PRP) and hyaluronic acid to improve tissue regeneration and healing.

RegenPRP™ - ATS

RegenPRP™ combined with ATS (Autologous Thrombin Serum) is an advanced approach to tissue regeneration that uses autologous thrombin-enriched platelet-rich plasma (PRP) to maximise healing effects.

RegenExtracell®

RegenExtracell is an innovative tissue regeneration treatment using an extracellular matrix enriched with platelet-rich plasma (PRP).

RegenWound

RegenWound is a fully autologous solution prepared from the patient’s own blood, with the objective of providing a standardised and reproducible approach for clinical use.

Regulatory

Manufacturers of medical devices based outside the EU must designate an Authorized Representative (EU-REP) established within the EU in order to meet the CE requirements for placing medical devices on the EU market.

Quality Management

Regen Lab Quality System Management ensures the consistency of our products quality in total GMP compliance.

Our production facility rooms atmosphere is monitored to satisfy non-pyrogenic medical devices manufacturing.

Patents

As a leader in the PRP&HA regenerative field and as an innovation-driven company, Regen Lab SA has devoted important resources since 2004 to put on the market pioneering and diversified products constituting a complete set of tools/technologies for the medical community.